Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|April 27, 2020

Pharm-Olam, IACOR Collaborate on Audit Certification

Until now there has not been an industry standard for clinical research auditing, but CRO Pharm-Olam and IAOCR have addressed that. Pharm-Olam developed a 12-week program, Core Global Competencies for Clinical Research Auditing, which IACOR has independently accredited to ensure consistently high standards of clinical research auditing across the industry. Individuals will be designated as Internationally Qualified Clinical Research Auditors, designated letters of AIACR. Pharm-Olam is funding the program for qualified members of its vendor network; however, the program is available to all individuals to gain the professional status. 

For more information, click here.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.